...
首页> 外文期刊>Acta Pharmacologica Sinica >Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells
【24h】

Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells

机译:RNA干扰对A549细胞表皮生长因子受体表达的抑制作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM: To investigate the biological features of A549 cells in which epidermal growth factor (EGF) receptors expression were suppressed by RNA interference (RNAi). METHODS: A549 cells were transfected using short small interfering RNAs (siRNAs) formulated with Lipofectamine 2000. The EGF receptor numbers were determined by Western blotting and flowcytometry. The antiproliferative effects of sequence specific double stranded RNA (dsRNA) were assessed using cell count, colony assay and scratch assay. The chemosensitivity of transfected cells to cisplatin was measured by MTT. RESULTS: Sequence specific dsRNA-EGFR down-regulated EGF receptor expression dramatically. Compared with the control group, dsRNA-EGFR reduced the cell number by 85.0 %, decreased the colonies by 63.3 %, inhibited the migration by 87.2 %, and increased the sensitivity of A549 to cisplatin by four-fold. CONCLUSION: Sequence specific dsRNA-EGFR were capable of suppressing EGF receptor expression, hence significantly inhibiting cellular proliferation and motility, and enhancing chemosensitivity of A549 cells to cisplatin. The successful application of dsRNA -EGFR for inhibition of proliferation in EGF receptor overexpressing cells can help extend the list of available therapeutic modalities in the treatment of non-small-cell lung carcinoma (NSCLC).
机译:目的:研究通过RNA干扰(RNAi)抑制表皮生长因子(EGF)受体表达的A549细胞的生物学特性。方法:使用Lipofectamine 2000配制的短小干扰RNA(siRNA)转染A549细胞。通过Western印迹和流式细胞仪测定EGF受体的数目。使用细胞计数,集落测定和刮擦测定来评估序列特异性双链RNA(dsRNA)的抗增殖作用。通过MTT测量转染的细胞对顺铂的化学敏感性。结果:序列特异性dsRNA-EGFR显着下调了EGF受体的表达。与对照组相比,dsRNA-EGFR减少了85.0%的细胞数量,减少了63.3%的菌落,抑制了87.2%的迁移,并使A549对顺铂的敏感性增加了四倍。结论:序列特异性dsRNA-EGFR能够抑制EGF受体的表达,从而显着抑制细胞增殖和运动,并增强A549细胞对顺铂的化学敏感性。 dsRNA -EGFR在抑制EGF受体过表达细胞增殖中的成功应用可以帮助扩展非小细胞肺癌(NSCLC)治疗中可用治疗方式的范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号